Background. Evidence on the frequency of a positive family history of colorectal cancer (CRC) among individuals aged <55 years is lacking. General practice setting might be well suited for the identification of individuals in this above-average risk group. Objective. To determine the frequency of a reported positive family history of CRC among patients aged 40 to 54 years in a general practice setting. Methods. We conducted a cross-sectional study in 21 general practices in Germany. Patients aged 40 to 54 years were identified by means of the practice software and interviewed by health care assistants using a standardized four-item questionnaire. Outcome was occurrence of a positive family history of CRC, defined as at least one first-degree relative (FDR: parents, siblings, or children) with CRC. Further measurements were FDRs with CRC / colorectal polyps (adenomas) diagnosed before the age of 50 and occurrence of three or more relatives with colorectal, stomach, cervical, ovarian, urethel or renal pelvic cancer. Results. Out of 6723 participants, 7.2% (95% confidence interval [CI] 6.6% to 7.8%) reported at least one FDR with CRC and 1.2% (95% CI 0.9% to 1.5%) reported FDRs with CRC diagnosed before the age of 50. A further 2.6% (95% CI 2.3% to 3.0%) reported colorectal polyps in FDRs diagnosed before the age of 50 and 2.1% (95% CI 1.8% to 2.5%) reported three or more relatives with entities mentioned above. Conclusion. One in 14 patients reported at least one FDR with CRC. General practice should be considered when defining requirements of risk-adapted CRC screening.
Introduction
The disease burden from colorectal cancer (CRC) is substantial. In Europe, 345 000 cases and 152 000 deaths were attributable to CRC in 2012 (1) . Besides age and behavioral factors, a positive family history is an established risk factor (2) (3) (4) . In this case, the risk of developing CRC is increased two to four times compared to the general population (3, 4) . Apart from the higher risk, it was estimated that a positive family history brings the risk of developing CRC forward by around 10 years (5) . International guidelines give partly differing recommendations on the age at which screening should be initiated in case of a positive family history (6) (7) (8) (9) (10) (11) . The German guideline recommends colonoscopy starting 10 years before the age at diagnosis of index patient (at the latest at the age of 40 to 45 years) (10) .
Data on how often individuals under the age of 55 have a positive family history of CRC might contribute to defining requirements in risk-adapted screening. Additional evidence would therefore support policy making regarding organized screening programs. A former cross-sectional study looking at the assessment of positive family history of CRC in individuals under the age of 55 was carried out using a postal questionnaire in a health insurance population. It showed that the proportion of affected participants was as high as 16% (12) . As more people participated in the survey may have been those who knew their relatives had been affected, the high proportion may have resulted from selection bias.
A potential approach to overcome this pitfall is data collection in a general practice setting. Based on the trusting relationship between patients and practice team, high response rates and improved data quality can be expected. Using practice software to indentify eligible patients allows a proper assessment in all patients with and without a known family history of CRC. Furthermore, a recent study demonstrated that a simple questionnaire to assess the family history of common diseases in general practice shows high performance (13) . According to the recommendations in the 'European Guideline for Quality Assurance in CRC Screening and Diagnosis', patients can be spoken to personally (6) . Under these conditions, we developed a cross-sectional study to determine the frequency of a positive family history of CRC (first-degree relative with CRC) among 40-to 54-year-old individuals in a German general practice setting.
Methods

Study design and setting
This cross-sectional study was conducted in general practices in the state of Hesse, Germany. We described all procedures in the published study protocol and registered the study in the German Clinical Trials Register (DRKS00006277) (14, 15) . Data collection took place between November 2014 and August 2015.
Participants
We recruited practices through a regional network of research practices (16) . Eligibility criteria for practices were as follows: at least one general practitioner (GP) or specialist in internal medicine and one health care assistant (HCA) were willing to participate in the study, the practice provided health services to persons with statutory health insurance and had a software that was capable of detecting eligible patients, the practice was located in the state of Hesse, Germany and had a fridge (4°C-8°C) and centrifuge.
Eligibility criteria for patients were as follows: patients aged between 40 and 54 years, who regularly attended the participating practice (no locum, no patients with consultation during travelling) and had had at least one contact with the GP during the previous 12 months. A list of patients who fulfilled the eligibility criteria was obtained in every participating practice by means of the practice software.
Data measurement
The primary aim was to measure how often a positive family history of CRC, defined as at least one first-degree relative (FDR: parents, siblings, or children) with CRC, was reported by the patients. We also measured the reported occurrence of CRC in FDRs diagnosed before the age of 50, the frequency of FDRs with colorectal polyps (adenoma) diagnosed before the age of 50 and the frequency of three or more affected relatives with colorectal, stomach, cervical, ovarian, urethel or renal pelvic cancer. To determine this, we used an existing short four-item questionnaire with dichotomous answer categories (yes/no), developed by the 'Netzwerk gegen Darmkrebs e.V.' (see Table 1 ) (17) . This instrument is mentioned in the German Evidence-based Guideline for CRC and is already used in practice (10) . In a former validation study, we were able to show that the first question on FDRs with CRC allows an identification of affected individuals with high sensitivity (100%) and good specificity (97%) (18) .
Study procedures
Based on a sample-size calculation, we planned to recruit 8750 patients. Taking into account possible non-participants among eligible patients, we planned to stop recruiting practices after we had a total of more than 12 000 eligible patients on the generated lists (15) . During the 8-month data collection period for each practice, the HCAs contacted the patients on the generated lists and conducted a structured interview on their family history of CRC. Patients were interviewed during routine visits to practices or by telephone. During the interviews, the HCA filled in the predefined lists of patients and added answers to the four-item questionnaire and further information on date of birth, gender and patient id from the practice software. Patients with a positive family history of CRC were invited for consultation with their GP. For this purpose, we developed an evidence-based decision aid on prevention strategies and trained the GPs in providing advice to the patients. Additionally, these patients were invited to participate in a further part of the study as described in the published study protocol (15) . Results regarding the primary research question will be reported here.
To ensure data quality, we piloted all procedures and documents and performed on-site monitoring visits during the study period. Population data from the German Federal Statistical Office were used to compare age and gender of participants with the general population (19) .
Statistical methods
The data were analyzed using descriptive statistics. Results were stratified according to gender and age group (40 to 44, 45 to 49, and 50 to 54 years). Continuous normally distributed data are described using mean and standard deviation. Not normally distributed continuous variables are described by median and range. Categorical data are described using absolute and relative frequencies. The frequency of positive family history is reported with 95% confidence intervals (CIs), calculated using bootstrapping. Differences in reported frequencies in subgroups were exploratively checked using χ 2 tests. Evidence for a difference was assumed if P was less than 0.05. No adjustment for multiple testing was done. In addition, we calculated the number of patients who had to be interviewed to identify one case of a positive family history of CRC. To assess data quality, we considered missing values in a sensitivity analysis. IBM SPSS© for windows version 22.0 was used to conduct the statistical analysis (SPSS Inc., Chicago, IL).
Results
Forty eligible practices agreed to participate. We stopped recruiting of practices once the number of 12 000 eligible patients was exceeded in the 21st practice. Overall, 21 (52.5%) practices with 30 GPs and 36 HCAs conducted the study. Of the 12 184 eligible patients, 6723 (55.2%) participated and were interviewed on family history of CRC during the 8-month data collection period. All numbers at each stage of the study, as well as reasons for non-participation, are shown in the flow chart in Figure 1 .
Characteristics of practices, general practitioners, health care assistants and patients
Characteristics of participating practices, GPs and HCAs are summarized in Table 2 .
The mean (SD) age of participants was 47.4 (4.0) years. The proportion of female participants was 56.2% and therefore greater than the proportion of females in the general population (49.5%). The distribution of age groups was largely similar to that in the general population (Table 3) . Nearly half the participants (44.9%) were interviewed during a routine practice visit, while the others were interviewed by telephone.
Reported positive family history of CRC
At least one FDR with CRC was reported by 7.2% (95% CI 6.6% to 7.8%). Thus, every 14th interviewed patient reported a positive family history of CRC. The frequency of FDRs with CRC varied between the age groups: 5.5% in the 40 to 44 age group, 6.9% in the 45 to 49 age group and 8.6% in the 50 to 54 age group reported having at least one FDR with CRC (P = 0.001) ( Table 4) .
Among all participants, 1.2% (CI 0.9% to 1.5%) reported having an FDR with CRC diagnosed before the age of 50. FDRs with a polyp (adenoma) diagnosed before the age of 50 were reported by 2.6% (CI 2.3% to 3.0%). Female participants gave a positive answer to this question more often than male participants (3.4% versus 1.7%, P < 0.001). Furthermore, 2.1% (CI 1.8% to 2.5%) reported having three or more relatives who had had colorectal, stomach, cervical, ovarian, urethel or renal pelvic cancer. Female participants also answered this question positively more often than male participants (2.7% versus 1.4%, P < 0.001) ( Table 4 ). In total, 10.1% of all participants answered at least one question positively.
Sensitivity analysis: missing values
The frequency of missing answers differed depending on the question: We obtained 222 (3.3%) missing values for the question on colorectal polyps (adenoma) in FDRs, and between 16 (0.2%) and 64 (1.0%) for the remaining three questions. To analyze the sensitivity of our results, we included missing values in a second analysis and calculated results for all 6723 participants. Under these conditions, some of the relative frequencies were slightly lower. Overall, the percentages varied by a maximum of 0.1% compared to the analysis without missing values in the main analysis. To ensure data quality, we also checked differences in the reported frequencies of a positive family history between practices. We did not find any outlier.
Discussion
This study is the first to assess the frequency of a positive family history of CRC in a German general practice setting. The frequency of reported family history of CRC among younger individuals aged 40 to 54 years was 7.2% (95% CI 6.6% to 7.8%). This means that to detect one case with at least one affected FDR with CRC in a general practice setting, an average of 14 patients had to be interviewed. We also found that 1.2% (95% CI 0.9% to 1.5%) of participants reported having FDRs with CRC diagnosed before the age of 50. Consistent with former studies, older participants more often reported having an FDR with CRC than younger participants (20, 21) . This is probably because their relatives are also older and therefore have more often developed CRC (2). The distribution of age in the study sample was largely comparable with the general population. A higher proportion of participants were female than in the general population. In Germany, more females have a GP and they make more often use of outpatient service than males in this age group (22) . In line with existing evidence, our results also indicate that females report more often having a family history of cancer than males (20) . These differences between female and male participants might point to a possible recall bias. One could speculate that women are more interested in their families and might therefore know more about health problems of their relatives.
This study has several strengths. The participation rate was satisfying: 55.2% of eligible patients agreed to participate in the interview on their family history. We assume that this result reflects the trusting relationship between practice team and patients. Data collection was conducted in a routine-care situation and we explicitly collected data on all eligible patients with and without a known family history of CRC. A sensitivity analysis did not indicate any major bias. The identification of eligible patients was performed accurately by means of practice software, we conducted on-site monitoring visits and provided telephone support. Additionally, we registered the study and defined all procedures in the published study protocol before the start of data collection (15) .
The study also has limitations. There is some debate as to the validity of reported family history. Some studies have reported low sensitivity (23, 24) . To avoid any such bias, we piloted the questionnaire in a prestudy. We were able to measure high sensitivity (100%) and good specificity (97%) for the first question on FDRs with CRC, but the remaining three questions have not yet been validated. The answers to these questions should therefore be interpreted with caution. We obtained a high frequency of positive answers to Question 4 addressing a possible hereditary risk. We assume that the design of this question led to a number of false-positive answers and also to a low specificity regarding hereditary risk. However, we used an existing questionnaire in this study, which is mentioned in the German guideline on CRC, and a positive answer to any question will always lead to further investigations on family history of CRC (10, 18) .
Further, it is difficult to link cancer registries with other registry data due to strict privacy policies in Germany. Although the choice of a general practice setting means the coverage of the population is high, some individuals do not consult a GP regularly. A large survey found that 78.4% to 79.2% of the population aged 40 to 59 has a GP and at least one contact annually. Additionally, more women (80.8% to 81.3%) than men (75.4% to 77.6%) in this age group have a GP (22) . The HCAs in the practices were not able to invite (or try to invite) 2293 of eligible patients for participation due to time constraints. This indicates that the data collection period was calculated too short, but this also indicates that there is more capacity in routine care. Under consideration of all effectively invited eligible patients and eligible patients who were tried to invite (n = 9891), we achieved a higher participation rate of 68%. The study mainly took place in a network of research practices, and existing evidence shows some differences in practice structures between GPs in research practices and GPs who are not involved in research (25, 26) .
Only a few former studies have obtained data on positive family history of CRC from individuals aged 40 to 54 years or have reported stratified results for this specific age group. This should be taken into account when comparing results. However, existing data often show higher frequencies. Pieper et al. (12) found that 16% in a German health insurance population reported a positive family history. Katalinic et al. (27) used the same questionnaire to calculate the prevalence of individuals with FDRs with CRC in Germany on the basis of existing literature. They reported a proportion of 6.4% to 14.0% in individuals aged 40 to 54 years. Mai et al. (28) found the prevalence of a reported positive family history (FDR with CRC) to be 7.6% among 45-to 54-year-old participants in a telephone survey in the USA. A number of further studies have explored the prevalence of a positive family history of CRC among other age groups and with differing definitions of a positive family history. In consequence, the frequencies vary between 6.1% and 11.2% (20, 21, (29) (30) (31) . None of these studies explored the family history of CRC by means of structured interviews in a general practice setting.
Young individuals with increased risk due to a positive family history are not explicitly addressed in current CRC screening in Germany. While there is no risk-adapted organized screening program, opportunistic screening with Fecal Occult Blood Tests is provided for the general population aged 50 years and older. The cost of having a screening colonoscopy is covered by the German statutory health insurance from the age of 55 years (32) . Contrariwise, the German guideline on CRC recommends colonoscopy for individuals with increased risk due to a positive family history of CRC starting 10 years before the age at diagnosis of index patient (at the latest at the age of 40 to 45 years) (10) . To the best of our knowledge, there is some utilization of screening colonoscopy among individuals aged <55 years with familial risk of CRC, but there is no data from studies available.
The results of this study suggest that a relevant proportion of the population aged 40 to 54 years has a positive family history and therefore an increased risk of developing CRC. In view to the large size of the study sample and the response rate, our results can be considered as representative for the German general practice setting and thus for the majority of the population. With a view to future organized screening programs, it might be valuable to consider GPs as gatekeepers for CRC screening for individuals with increased risk in younger age. However, this has to be examined in following studies. Furthermore, a key question remains unanswered: Until now, evidence on the usefulness of organized CRC screening in individuals under the age of 55 with a positive family history is lacking and health policy would benefit from new evidence. In summary, we were able to present a basis for further research and quantified a potential burden for the population. Our results show that in a general practice setting, 1 in 14 patients aged 40 to 54 years reports a positive family history of CRC.
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